Simeon Kohl - 14 Sep 2026 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HCAT
Reported as of: 14 Sep 2026
Net transaction value: +$105,439
SEC form: 4
Accepted by SEC: 16 Sep 2026, 16:52:48 UTC
Prior SEC filing: 21 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Benjamin Landry, as Attorney-in-Fact

Key filing fact

Simeon Kohl filed Form 4 for Health Catalyst, Inc. (HCAT) on 16 Sep 2026.

Key facts

This page summarizes Simeon Kohl's Form 4 filing for Health Catalyst, Inc. (HCAT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Sep 2026, 16:52.

Change

Previous filing in this sequence was filed on 21 Oct 2025.
Current net transaction value: +$105,439.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001703807 Primary reporting owner

Kohl Simeon

Relationship: Chief Executive Officer, Director
Address: 10897 S. RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Signature: /s/ Benjamin Landry, as Attorney-in-Fact
Signature date: 16 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Award

Transaction value
Shares: +2,747,385
Change %: +5495%
Price: $0.000000^*
Shares after: 2,797,385
Date: 14 Sep 2026
Ownership: Direct
Footnotes: F1

HCAT transaction

Common Stock

Purchase

Transaction value: $105,439
Shares: +59,000
Change %: +2.1%
Price: $1.79
Shares after: 2,856,385
Date: 14 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments.